Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - aluminium hydroxide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

winwa medical sdn. bhd. - magnesium hydroxide; aluminium hydroxide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

winwa medical sdn. bhd. - magnesium hydroxide; aluminium hydroxide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kck pharmaceutical industries sdn. bhd. - magnesium trisilicate; aluminium hydroxide; polymethylsiloxane,activated/simethicone -

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium oxide, hydrated - chewable tablet - 400mg/400 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Kenya - English - Pharmacy and Poisons Board

aluminium hydroxide,magnesium… - gel - aluminium hydroxide 306 mg,magnesium hydroxide… - antacids with antiflatulents

Singapore - English - HSA (Health Sciences Authority)

sunward pharmaceutical private limited - aluminium hydroxide (dried gel) - tablet, film coated - 600 mg - aluminium hydroxide (dried gel) 600 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - aluminium hydroxide dried - chewable tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - aluminium hydroxide dried - chewable tablet - 500mg

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.